Patents Examined by Aaron J Kosar
  • Patent number: 11793767
    Abstract: The invention relates to the use of effective amount of Pelargonium graveolens essential oil or extract or constituents thereof selected from a group consisting of: (S)(?)citronellol, linalool, menthone and isomenthone or any combination thereof, in the preparation of a medicament for treating a mammal suffering from or susceptible to a neurodegenerative condition which can be improved or prevented by inhibition of acetylcholinesterase (ACliE).
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: October 24, 2023
    Assignee: THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT AGRICULTURE RESEARCH ORGANIZATION
    Inventors: Anat Elmann, Uzi Ravid
  • Patent number: 11793852
    Abstract: An application of Longhu Rendan in preparing a medicament for preventing and/or treating liver fibrosis. The Longhu Rendan has significant effect in improving fibrosis, and its effect in anti-liver fibrosis and liver protection is equivalent to those of a positive drug silybin.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: October 24, 2023
    Assignee: Shanghai Zhonghua Pharmaceutical Co., Ltd
    Inventors: Jiahua Jin, Biye Wang, Liqin Ding, Wujie Cao, Xiaoping Zhu, Tian Lan
  • Patent number: 11786506
    Abstract: A transmucosal psychoactive alkaloid composition including a psychoactive alkaloid extract or synthetic psychoactive alkaloid. The alkaloids in the extract are predominantly dephosphorylated rather than phosphorylated. The transmucosal psychoactive alkaloid composition also includes a mucoadhesive polymer, a carrier, and optional further excipients. The non-ingestive composition may be taken orally through the mucosa. A process for obtaining an oral transmucosal psychoactive alkaloid composition includes dephosphorylating the alkaloid during extraction, purifying the extracted alkaloid and standardizing to a specific concentration by adding measured quantities of excipients.
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: October 17, 2023
    Assignee: Psilo Scientific Ltd
    Inventors: Ryan Moss, Benjamin Lightburn, Lisa Ranken
  • Patent number: 11779626
    Abstract: The present invention relates to a composition for enhancing immunity or a composition for preventing or ameliorating neurodegenerative diseases, both of which contain, as an active ingredient, a mixture extract of goji berries, mulberries and jujubes or an extract mixture thereof.
    Type: Grant
    Filed: July 19, 2022
    Date of Patent: October 10, 2023
    Assignee: COSMAX NS, INC.
    Inventors: Kwang Soo Baek, Hyunji Kim, Su Young Choi, Jin Hak Kim, Jae Seok Shim, Young Min Park, Sang Woo Kim, Mann-Seok Yoon, Yoon Jong Lee
  • Patent number: 11779610
    Abstract: Methods are provided for treatment of several conditions of one or more body features, where the method comprises implanting an acellular soft tissue-derived matrix in, on, proximate to, or a combination thereof, the body feature, wherein the acellular soft tissue-derived matrix comprises a delipidated, decellularized adipose matrix. The delipidated, decellularized adipose tissue matrix is produced by delipidating an adipose tissue sample, followed by decellularizing the delipidated adipose tissue sample. The resulting matrix contains a proportion of lipids which is less than the proportion of lipids contained in a matrix produced by decellularizing an adipose tissue sample prior to delipidating. The delipidated, decellularized adipose matrix may be provided as particles, a slurry, a paste, a gel, an injectable form, or in some other form.
    Type: Grant
    Filed: November 29, 2021
    Date of Patent: October 10, 2023
    Assignee: Musculoskeletal Transplant Foundation
    Inventors: Yen-Chen Huang, Asia Ivery, Bryan Choi, Benjamin Schilling, Manh-Dan Ngo
  • Patent number: 11773154
    Abstract: The present disclosure provides, inter alia, engineered microbes expressing recombinant LEKTI domains that are effective to treat or ameliorate the symptoms of Netherton Syndrome. In certain embodiments, compositions, methods, and kits are provided comprising LEKTI domain expressing microbes.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: October 3, 2023
    Assignee: Azitra Inc
    Inventors: Travis Michael Whitfill, Azim Momin Munivar
  • Patent number: 11759495
    Abstract: Disclosed are compositions of matter, treatments and protocols useful for induction of T regulatory cells in response to inflammation, as well as inhibition of suicidal ideations and/or neuroinflammation. In some embodiments the invention teaches the administration of a therapeutic combination of ingredients comprising of minocycline, pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal undergoing upregulation of inflammatory mediators. In another embodiment, the invention teaches administration of said therapeutic combination to a mammal infected with said SARS-CoV-2 and/or possessing suicidal ideations. In some embodiments dosage of said therapeutic combination is based on inflammatory and/or immunological parameters observed in patients.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: September 19, 2023
    Assignee: Therapeutic Solutions International, Inc.
    Inventors: Thomas E. Ichim, Timothy G. Dixon, Kalina O'Connor
  • Patent number: 11752124
    Abstract: A composition of chlorogenic acids and method of its use and manufacture in the treatment of metabolic disorders. The composition can be obtained from sunflower seed extract, including Helianthus annulus seeds.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: September 12, 2023
    Assignee: Vidya Herbs, Inc.
    Inventor: Kodimule Shyam Prasad
  • Patent number: 11744918
    Abstract: Compositions comprising translucent, dehydrated placental tissue and methods of preparing and using those tissues are provided. Repeated dehydration techniques may produce translucent, dehydrated placental tissues, including translucent, dehydrated placental membrane and umbilical cord, with improved visualization and/or handling characteristics. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, muscle, dental region, or dura, including burns, comprising applying the translucent, dehydrated placental tissues of the invention to the wound.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: September 5, 2023
    Assignee: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Annelise Mowry Roy
  • Patent number: 11744864
    Abstract: The present invention provides compositions comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy, particularly when administered systemically. This invention further relates to a modified krill oil composition enriched in LPC-DHA and LPC-EPA, methods of making and methods of using to treat neurological and ocular disorders.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: September 5, 2023
    Assignee: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Finn Myhren, Petter-Arnt Hals, Nils Hoem, Andreas Berg Storsve, Papasani V. Subbaiah, Poorna Yalagala, Sugasini Dhavamani, Leon Tai
  • Patent number: 11738115
    Abstract: Compositions comprising translucent, dehydrated placental tissue and methods of preparing and using those tissues are provided. Repeated dehydration techniques may produce translucent, dehydrated placental tissues, including translucent, dehydrated placental membrane and umbilical cord, with improved visualization and/or handling characteristics. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, muscle, dental region, or dura, including burns, comprising applying the translucent, dehydrated placental tissues of the invention to the wound.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: August 29, 2023
    Assignee: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Annelise Mowry Roy
  • Patent number: 11732015
    Abstract: A method for drying moist jellyfish matter is provided. Jellyfish matter undergoes a controlled drying process until the jellyfish matter comprises a dried flake or mass.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: August 22, 2023
    Inventor: Ahmad Alkayali
  • Patent number: 11723942
    Abstract: Disclosed are powder solid compositions including a hydroalcoholic extract of Bergamot fruit (Citrus aurantium var. bergamia) and at least one phospholipid. Also disclosed is a process for the preparation of the compositions. The compositions are useful for the prevention and/or treatment of dysmetabolic syndromes, dyslipidemias and type 2 diabetes.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: August 15, 2023
    Assignee: INDENA S.P.A.
    Inventors: Massimo Ronchi, Giacomo Mombelli
  • Patent number: 11717552
    Abstract: An extract of an herbal composition comprising at least two different dried plants useful as antimicrobial and/or antibiofilm agent in the treatment or prevention of microbial infections caused by bacteria, such as for example Escherichia, Klebsiella, Listeria, Pseudomonas, Salmonella, Streptococcus or Staphylococcus, or by fungi, such as for example is herein described. It has been found that in such extract, the active ingredients exert their biological effects in a synergistic manner. The extract may constitute the active ingredient of a food supplement, a nutraceutical, pharmaceutical or cosmetic composition or a functional food or a food additive. A process for preparing said extract is also described here.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: August 8, 2023
    Assignee: ALPHANOSOS S.A.S.
    Inventors: Pascal Mayer, Laure Breuils
  • Patent number: 11717596
    Abstract: Methods and compositions for the biological repair of cartilage using a hybrid construct combining both an inert structure and living core are described. The inert structure is intended to act not only as a delivery system to feed and grow a living core component, but also as an inducer of cell differentiation. The inert structure comprises concentric internal and external and inflatable/expandable balloon-like bio-polymers. The living core comprises the cell-matrix construct comprised of HDFs, for example, seeded in a scaffold. The method comprises surgically removing a damaged cartilage from a patient and inserting the hybrid construct into the cavity generated after the foregoing surgical intervention. The balloons of the inert structure are successively inflated within the target area, such as a joint, for example. Also disclosed herein are methods for growing and differentiating human fibroblasts into chondrocyte-like cells via mechanical strain.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: August 8, 2023
    Assignee: SpinalCyte, LLC
    Inventors: Lionel C. Sevrain, Sylvie Y. Verdier-Sevrain
  • Patent number: 11718830
    Abstract: Systems and methods for creating cell sheets with high extracellular (ECM) content, while controlling cell alignment, are described. The method is simple, easy to perform, has a low-cost, and uses non-toxic and food-grade and food-safe materials. The method allows for cell alignment in sophisticated patterns using simple molding process with 3D printed molds prepared with cheap open-source 3D printers and using different types of filament materials. The method allows for the reuse of the silicone-based membranes by simple autoclaving and/or an isopropanol washing step. The method also creates multi-layer cell constructs and induced ECM production with optional ECM crosslinking using food-grade materials resulting in strong sheets formed in a short process that can be formed using simple scraping.
    Type: Grant
    Filed: August 8, 2022
    Date of Patent: August 8, 2023
    Inventor: Alireza Shahin-Shamsabadi
  • Patent number: 11712450
    Abstract: The present invention is directed to a method and a composition for producing and using a plant-based biocidal solution. The plant-based biocidal solution contains a bioactive material and a plant-based substance formed from the cellular material of a plant. The plant-based substance is capable of binding to the bioactive material. In some embodiments, the bioactive material is hydrogen peroxide. The hydrogen peroxide can be added exogenously or generated endogenously. In accordance with further embodiments, the plant-based biocidal solution can be applied to a target, thereby impairing the target. In some embodiments, the target can be a pathogen. In accordance with another embodiment, the plant-based substance of the plant-based biocidal solution can form a microscopic cluster, a complex, or an aggregate for providing sufficient bioactive material to overcome the defense mechanism of the target.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: August 1, 2023
    Assignee: LIVELEAF HOLDINGS, LLC
    Inventors: Alexander L Huang, Gin Wu
  • Patent number: 11712415
    Abstract: A soft, chewable and orally dissolvable and/or disintegrable product includes a biopolymer-sugar based matrix and botanical powder dispersed throughout the biopolymer-sugar based matrix. The biopolymer-sugar based matrix includes at least one biopolymer, at least one sugar and optional additives. Soft, chewable and orally dissolvable and/or disintegrable product can also include flavor beads.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: August 1, 2023
    Assignee: Philip Morris USA Inc.
    Inventors: Feng Gao, Shalva Gedevanishvili, Shengsheng Liu, Munmaya K. Mishra, William R. Sweeney, Randall Baren, Qinglin Li, Darin Colassaco, Salem Chouchane
  • Patent number: 11712457
    Abstract: A Syringa microphylla seed extract includes the following components by weight based on a total weight of the Syringa microphylla seed extract: 0.4944-0.7142 mg/g of echinacoside, 6.624-7.617 mg/g of oleuropein, 0.4276-0.6309 mg/g of verbascoside, 3.927-4.684 mg/g of syringin, and 4.505-5.250 mg/g of forsythiaside B. A method of preparing the Syringa microphylla seed extract is disclosed. A composition for treating antibiotic-resistant infections that includes the Syringa microphylla seed extract is also disclosed.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: August 1, 2023
    Assignee: SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Qianqian Zhao, Jialin Li, Dan Yang, Jingyi Li, Liang Xin, Chunyang Shi, Xiaolin Xie, Dezhu Zhang, Ruina Bian, Xingke Ju, Chengyuan Liang, Yanjun Li, Qiao Zeng
  • Patent number: 11707498
    Abstract: Homeopathic spray, gel, and rinse compositions containing tinctures of Arnica montana, Calendula officinalis, Chamomilla, Ignatia amara, Echinacea purpurea and/or Echinacea angustifolia are disclosed, along with homeopathic compositions containing tinctures of Calendula officinalis, Echinacea purpurea, Plantago major, and Azadirachta indica. Methods of using, and kits containing, the homeopathic spray, gel, rinse and other compositions for maintaining oral care and reducing inflammation, pain, and bruising after oral surgery are provided.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: July 25, 2023
    Assignee: STELLALIFE, INC.
    Inventor: Walter Tatch